Quick Answer
Vir Biotechnology, Inc. reported Shares Outstanding of 139.47 million shares for fiscal year 2025.
Vir Biotechnology, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 139.47M | +1.8% |
| 2024 | 136.96M | +1.6% |
| 2023 | 134.78M | +1.2% |
| 2022 | 133.24M | +1.6% |
| 2021 | 131.16M | +2.9% |
| 2020 | 127.42M | +18.4% |
| 2019 | 107.65M | +1115.2% |
| 2018 | 8.86M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 139.02M | +1.7% | +0.1% |
| June 30, 2025 | 138.89M | +1.7% | +0.6% |
| March 31, 2025 | 138.06M | +1.6% | +0.8% |
| December 31, 2024 | 136.96M | +1.6% | +0.2% |
| September 30, 2024 | 136.71M | +1.6% | +0.1% |
| June 30, 2024 | 136.59M | +1.8% | +0.5% |
| March 31, 2024 | 135.84M | +1.4% | +0.8% |
| December 31, 2023 | 134.78M | +1.2% | +0.2% |
- Vir Biotechnology, Inc. showed an increase of +1.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, Vir Biotechnology, Inc.’s shares outstanding has grown by 1474.4% (from 8.86 million shares to 139.47 million shares).
- The most recent figure is from Vir Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: